Improving Regulatory Transparency for New Medical Therapies Act
Latest action · Sep 19, 2014 Placed on the Union Calendar, Calendar No. 451.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 26, 2014
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Improving Regulatory Transparency for New Medical Therapies Act - Amends the Controlled Substances Act to require any proceedings for the issuance, amendment, or repeal of a rule of the Attorney General for the classification of a controlled substance that are initiated at the request of the Secretary of Health and Human Services (HHS) to control a drug or other substance not previously scheduled, where the Secretary has recommended the drug or other substance be placed in schedule II, III, IV, or V, to be commenced not later than 120 days after receipt of written recommendations from the Secretary. Requires the final rule to be issued not later than 60 days after the date on which both the public comment period has closed and the new drug is the subject of an approved new drug application, unless a hearing on the proposed rule is granted by the Attorney General.
Directs the Attorney General, for the purposes of registration to manufacture a controlled substance in schedule III, IV, or V for use only in a clinical trial, to register an applicant, or serve upon the applicant an order to show cause why registration should not be denied, revoked, or suspended, not later than 180 days after receiving an application and all information necessary to make a determination about whether the issuance of such registration is inconsistent with the public interest.
Directs the Attorney General, for the purposes of registration to manufacture a controlled substance in schedule I or II for use only in a clinical trial, to: (1) issue a notice of application not later than 90 days after receipt of an application and all necessary information to issue such notice; and (2) register an applicant, or serve upon the applicant an order to show cause why registration should not be denied, revoked, or suspended, within 180 days following the close of the comment period and receipt of all information necessary to make a determination about whether the issuance of such registration is consistent with the public interest and with U.S. obligations under international treaties in effect on May 1, 1971, unless a hearing on the application has been granted pursuant to a provision of the Controlled Substances Import and Export Act regarding emergency situations.
Cosponsors 15
Members who signed on, in the order they did. Signatures ran from Mar 26, 2014 to Sep 8, 2014; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NJ | Frank Pallone, Jr. | Original | Mar 26, 2014 |
| R-TX | Michael C. Burgess | Apr 1, 2014 | |
| R-WA | Cathy McMorris Rodgers | Apr 3, 2014 | |
| R-TN | Marsha Blackburn | Apr 8, 2014 | |
| R-VA | H. Morgan Griffith | Apr 9, 2014 | |
| R-GA | Phil Gingrey | Apr 9, 2014 | |
| D-TX | Gene Green | Apr 10, 2014 | |
| R-OH | Robert E. Latta | Apr 29, 2014 | |
| D-NH | Carol Shea-Porter | May 19, 2014 | |
| D-NY | Eliot L. Engel | May 19, 2014 | |
| D-NC | G. K. Butterfield | May 20, 2014 | |
| D-NY | Paul Tonko | May 28, 2014 | |
| R-OH | Bill Johnson | May 29, 2014 | |
| R-GA | Doug Collins | Sep 8, 2014 | |
| R-MS | Gregg Harper | Sep 8, 2014 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 26, 2014Markup Jun 10, 2014Reported Jul 29, 2014 |
| Health Subcommittee | Referred Mar 28, 2014Markup May 28, 2014Reported May 28, 2014 | |
| House | Judiciary Committee | Referred Mar 26, 2014Markup Sep 10, 2014Reported Sep 19, 2014 |
| Crime and Federal Government Surveillance Subcommittee | Referred Apr 16, 2014Discharged Sep 9, 2014 |
Actions 16
Everything that happened, newest first.
- Sep 19, 2014Reported (Amended) by the Committee on Judiciary. H. Rept. 113-565, Part II.
- Sep 19, 2014Placed on the Union Calendar, Calendar No. 451.
- Sep 10, 2014Committee Consideration and Mark-up Session Held.
- Sep 10, 2014Ordered to be Reported (Amended) by Voice Vote.
- Sep 9, 2014Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.
- Jul 29, 2014Reported by the Committee on Energy and Commerce. H. Rept. 113-565, Part I.
- Jul 29, 2014House Committee on the Judiciary Granted an extension for further consideration ending not later than Sept. 19, 2014.
- Jun 10, 2014Committee Consideration and Mark-up Session Held.
- Jun 10, 2014Ordered to be Reported by Voice Vote.
- Jun 9, 2014Committee Consideration and Mark-up Session Held.
- May 28, 2014Subcommittee Consideration and Mark-up Session Held.
- May 28, 2014Forwarded by Subcommittee to Full Committee by Voice Vote .
- Apr 16, 2014Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Mar 28, 2014Referred to the Subcommittee on Health.
- Mar 26, 2014Introduced in House
- Mar 26, 2014Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee reports
Congressional Budget Office cost estimates 2
- Sep 25, 2014H.R. 4299, Improving Regulatory Transparency for New Medical Therapies ActAs ordered reported by the House Committee on the Judiciary on September 10, 2014
- Jun 27, 2014H.R. 4299, Improving Regulatory Transparency for New Medical Therapies ActAs ordered reported by the House Committee on Energy and Commerce on June 10, 2014
Constitutional authority
The sponsor’s statement, as printed in the page H2695.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 113-109 | DRUG ENFORCEMENT ADMINISTRATION59 pages | Judiciary Committee | Sep 18, 2014 |
| Serial No. 113-137 | IMPROVING PREDICTABILITY AND TRANSPARENCY IN DEA AND FDA REGULATION221 pages | Energy and Commerce Committee | Apr 7, 2014 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2862 | Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 | Related bill | Sep 18, 2014 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.
- Short Titles as Introduced
- Improving Regulatory Transparency for New Medical Therapies Act
- Short Titles as Reported to House
- Improving Regulatory Transparency for New Medical Therapies Act
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 2
Each version as it was printed, newest first.
- Sep 19, 2014Reported in House
- Mar 26, 2014Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.